James Darecca's Net Worth

-$339 Thousand

Estimate Recalculated Jun 7, 2024 03:18PM EST

Who is James Darecca?

James Darecca does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include HAEMONETICS CORP, Allergan plc, TherapeuticsMD, Inc., Prestige Consumer Healthcare Inc., and Actavis, Inc..

SEC CIK

James Darecca's CIK is 0001583903

Past Insider Trading and Trends

2020 was James Darecca's most active year for acquiring shares with 5 total transactions. James Darecca's most active month to acquire stocks was the month of February. 2017 was James Darecca's most active year for disposing of shares, totalling 7 transactions. James Darecca's most active month to dispose stocks was the month of February. 2020 saw James Darecca paying a total of $699,956.24 for 1,609,611 shares, this is the most they've acquired in one year. In 2020 James Darecca cashed out on 20,213 shares for a total of $137,820.10, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

HAEMONETICS CORP (HAE) Snapshot price: $77.075

EVP, Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+34.39%
4.44K
17.35K
May 17
Form 4
-5.58%
-763.00
$95.71
-$73,028.68
12.91K
May 15 - May 16
Form 4
-3.06%
-432.00
$93.33
-$40,318.56
13.67K
May 2
Form 4
+37.63%
3.86K
$89.21
-$31,134.29
14.1K
May 15 - May 16
Form 4
-4.03%
-430.00
$81.66
-$35,113.80
10.25K
May 2
Form 4
+80.89%
4.77K
10.68K
May 16
Form 4
5.9K
5.9K
May 2
Form 3
0
0
No matching records found

Allergan plc No price found

SVP Chief Accounting Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-9.84K
0
May 8
Form 4
-6.80%
-718.00
$191.95
-$137,820.10
9.83K
Mar 6
Form 4
+52.02%
3.61K
$193.84
$699,956.24
10.55K
Mar 2
Form 4
-1.31%
-92.00
$191.17
-$17,587.64
6.94K
Dec 31
Form 4
-6.29%
-472.00
$143.49
-$67,728.78
7.03K
Mar 7 - Mar 8
Form 4
+37.23%
2.04K
$137.51
$279,970.36
7.5K
Mar 6
Form 4
-2.04%
-114.00
$139.12
-$15,859.68
5.47K
Mar 4
Form 4/A
+45.84%
1.83K
$153.22
$279,779.72
5.81K
Mar 7
Form 4
-2.63%
-147.00
$133.66
-$19,648.02
5.45K
Dec 31
Form 4
-1.39%
-79.00
$153.50
-$12,126.50
5.6K
Mar 8
Form 4
+39.33%
1.6K
$153.22
$245,611.66
5.68K
Mar 7
Form 4
-3.46%
-146.00
$146.28
-$21,356.62
4.08K
Mar 2 - Mar 5
Form 4
-2.31%
-100.00
$163.58
-$16,358.00
4.22K
Dec 29
Form 4
+22.68%
799
4.32K
Oct 26
Form 4
+40.08%
1.01K
$239.52
$241,529.12
3.52K
Mar 7 - Mar 8
Form 4
-5.20%
-138.00
$245.63
-$33,896.94
2.52K
Mar 4 - Mar 5
Form 4
+5.82%
146
$229.32
$33,480.72
2.65K
Feb 1
Form 4
+57.38%
914
$284.43
$259,969.02
2.51K
Mar 8
Form 4
+31.11%
378
$295.70
-$23,064.60
1.59K
Mar 5
Form 4
+259.47%
877
$296.14
$259,714.78
1.22K
Mar 4
Form 4
0
0
Jul 1
Form 4
338
$197.05
$66,602.90
338
May 9
Form 3
0
0
No matching records found

TherapeuticsMD, Inc. (TXMD) Snapshot price: $2.28

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
123.83K
$0.87
-$81,203.19
123.83K
Aug 10 - Aug 12
Form 4
0
0
Jul 1
Form 4/A
0
0
Jun 18
Form 4
0
0
Jun 18
Form 3
0
0
No matching records found

Prestige Consumer Healthcare Inc. (PBH) Snapshot price: $63.2

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.29K
2.29K
Aug 1
Form 3
0
0
No matching records found

Actavis, Inc. No price found

Chief Accounting Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found